Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host cell surface carbohydrates are complex sugar structures (often oligosaccharides) displayed on the outer surface of animal and human cells, usually attached to membrane proteins (glycoproteins) or lipids (glycolipids)[2][3][4][7]. These carbohydrates serve as critical points for cell recognition, adhesion, and signaling, enabling the immune system to distinguish host cells from pathogens, and facilitating numerous cell-cell communications essential to normal physiology[1][3][5][7]. They play major roles in infection, providing binding sites (receptors or co-receptors) for viral, bacterial, or parasitic pathogens—for example, facilitating viral entry via recognition by influenza hemagglutinin, or norovirus binding to histo-blood group antigens[2][6]. Cell surface carbohydrates are not a single defined molecule, but rather a diverse class of molecules with vastly variable specificities and structures depending on cell type, tissue, and physiological state. They are implicated in diseases such as cancer (altered glycosylation in tumor cells supports metastasis and immune evasion) and are important markers such as the ABO blood group antigens[2][4][5]. While therapeutically targetable in concept (e.g., via carbohydrate-based vaccines or inhibitors of pathogen binding), their ubiquity and structural diversity present significant challenges for selectivity and specificity. Key organizational clarifications: - The phrase "Host cell surface carbohydrates" is a broad molecular class, not a specific molecule or protein target, which makes direct targeting complex or non-specific[1][2][3][4][6][7]. - Many individual molecules (~glycoproteins, glycolipids, specific carbohydrate epitopes) fall within this class, with each potentially representing a target in specific therapeutic contexts. If a more structured molecular target is desired (such as a particular glycoprotein or glycan epitope), a more specific name should be used.
Blockade or masking of recognition sites to inhibit pathogen binding; Alteration of glycosylation patterns to reduce cell adhesion/metastasis; Vaccine components targeting glycan epitopes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host cell surface carbohydrate.